This paper introduces the MIX-Seq method for multiplexed transcriptional profiling of pooled cell lines that undergo drug treatment. Individual cell line identities were determined based on their single-nucleotide polymorphism (SNP) profiles. This method enables profiling of chemical or genetic perturbation response in pools of 100+ cancer cell lines.
PRISM will be accepting submissions for our next screen
January 27 – February 14, 2025!
This screen will be for DMSO-soluble small molecules only against the PRISM collection of 930 cancer cell lines.